Auditory deep sleep stimulation in older adults at home: a randomized crossover trial.
Caroline Lustenberger, M Laura Ferster, Stephanie Huwiler...
https://pubmed.ncbi.nlm.nih.gov/35603302Actively Recruiting
Led by University of Bern · Updated on 2026-04-03
60
Participants Needed
1
Research Sites
30 weeks
Total Duration
U
University of Bern
Lead Sponsor
U
University of Zurich
Collaborating Sponsor
Researchers are investigating a non-invasive method to improve memory and slow cognitive decline in older adults by enhancing the quality of deep, slow-wave sleep (SWS). Dementia, a leading cause of death worldwide, is linked to disturbed sleep, especially the loss of SWS, which plays a key role in memory and clearing waste from the brain. Poor SWS may worsen memory loss and increase dementia risk. This study focuses on people with mild cognitive impairment and aims to test if phase-locked auditory stimulation (PLAS) can improve SWS and related brain functions. The study involves 60 older adults using a home-use SleepLoop device that delivers either real or sham (soundless) PLAS during sleep. Participants undergo two 4-week intervention periods separated by a 2-week washout phase. One group receives real PLAS first followed by sham stimulation, and the other group receives sham first then real PLAS. The device detects slow oscillations in sleep and delivers short sound stimuli during deep sleep to strengthen slow-wave brain activity. The stimulation is applied on weeknights, Monday to Friday, and is individually calibrated for each participant. Participants will play memory-testing serious games on weekdays during an adaptation week and throughout both intervention periods. Blood samples will be collected at baseline and after 4, 6, and 10 weeks to measure dementia-related markers. Sleep electrophysiology and cognitive tests will be performed regularly to assess changes. Researchers will monitor memory performance, brain activity during sleep, and blood biomarkers to evaluate the effects of PLAS. The total study duration includes adaptation, intervention, washout, and follow-up periods, extending up to 10 weeks for each participant.
CONDITIONS
Effects of Real vs. Soundless Acoustic Stimulation During Deep Sleep on Brain Activity, Memory, and Blood Biomarkers in Older Adults (60-85) With Mild Memory Impairment
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 1 week
Participants undergo an adaptation week with sleep-electrophysiology measurements and serious game practice on weekdays to prepare for the intervention periods.
Weekday visits for adaptation measurements and training
Duration - 4 weeks
Participants receive 4 weeks of phase-locked auditory stimulation (PLAS) or sham stimulation on weeknights (Monday to Friday) using the SleepLoop device during deep sleep to study effects on brain activity and memory.
Weekday usage from Monday to Friday during intervention
Duration - 2 weeks
Participants have a 2-week break without stimulation between the two intervention periods to wash out effects of the first treatment.
No visits required during washout
Duration - 4 weeks
Participants receive the alternate 4-week phase-locked auditory stimulation (PLAS) or sham stimulation on weeknights (Monday to Friday) using the SleepLoop device during deep sleep.
Weekday usage from Monday to Friday during intervention
Duration - 10 weeks total from baseline through last assessment
Participants are assessed for memory performance, brain activity, and blood biomarkers at baseline, after 4 weeks, after 6 weeks, and after 10 weeks to evaluate the effects of the interventions.
Assessments at baseline, 4 weeks, 6 weeks, and 10 weeks
Total: 1 location
1
University Hospital of Old Age Psychiatry and Psychotherapy, University of Bern
Bern, Switzerland, 3000 60
Actively Recruiting
M
Marc A Züst, PhD
K
Korian Wicki, Master
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Caroline Lustenberger, M Laura Ferster, Stephanie Huwiler...
https://pubmed.ncbi.nlm.nih.gov/35603302Marina Wunderlin, Marc A Züst, Elisabeth Hertenstein...
https://pubmed.ncbi.nlm.nih.gov/33406249Céline J Zeller, Marina Wunderlin, Korian Wicki...
https://pubmed.ncbi.nlm.nih.gov/38744792Marina Wunderlin, Céline Jacqueline Zeller, Samira Rafaela Senti...
https://pubmed.ncbi.nlm.nih.gov/38163288